
Leqembi shows lower progression rate in Alzheimer disease over 3 years, shows new data.
In approximately half of patients with Huntington disease, symptoms of depression, irritability/aggression, executive dysfunction, psychosis, cognitive decline, and dementia present long before progressive motor symptoms.




